(Q39144641)

9 September 2017

title

Hydroxychloroquine's Efficacy as an Antiplatelet Agent Study in Healthy Volunteers: A Proof of Concept Study (English)

1 reference

9 September 2017

0 references

S Achuthan

1

1 reference

9 September 2017

J Ahluwalia

2

1 reference

9 September 2017

N Shafiq

3

1 reference

9 September 2017

A Bhalla

4

1 reference

9 September 2017

A Pareek

5

1 reference

9 September 2017

N Chandurkar

6

1 reference

9 September 2017

Samir Malhotra

7

1 reference

9 September 2017

publication date

14 August 2014

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

9 September 2017

published in

1 reference

9 September 2017

volume

20

1 reference

9 September 2017

issue

2

1 reference

9 September 2017

page(s)

174-180

1 reference

9 September 2017

cites work

The unstable atheroma

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Aspirin resistance: focus on clinical endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

On the inhibitory effect of chloroquine on blood platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Hydroxychloroquine and postoperative thromboembolism after total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Insights into atherosclerosis therapy in antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Prevalence and correlates of metabolic syndrome in patients with rheumatoid arthritis in Argentina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

The effects of colchicine and hydroxychloroquine on the cyclo-oxygenases COX-1 and COX-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Prevention of the platelet alpha-granule release reaction by membrane-active drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Acidic Ca(2+) stores in platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

13-year long-term associations between changes in traditional cardiovascular risk factors and changes in fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Effect of medication on microvascular vasodilatation in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

Vascular elasticity of systemic lupus erythematosus patients is associated with steroids and hydroxychloroquine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248414546324

21 January 2018

Identifiers

DOI

10.1177/1074248414546324

1 reference

9 September 2017

1 reference